Supported by the Osteosarcoma Institute and Ethos Discovery, the MIMIC trial evaluates a new method of removing lung metastases in dogs, providing insights that can directly inform human osteosarcoma treatment and drug development.
Stories of Progress, Inspiration & Support
Research & Breakthroughs
Innovation and studies to improve patient outcomes
The U.S. Food and Drug Administration (FDA), the Osteosarcoma Institute (OSI), and others are coming together to shape the future of osteosarcoma clinical trials.
Veterinary oncologist Chand Khanna, DVM, PhD, explains how osteosarcoma in dogs is helping researchers unlock new possibilities for treating human patients.
See the life cycle of a research grant — from your initial donation to the Osteosarcoma Institute to research being conducted in the lab or clinic.
The OSI’s bold initiative brings a groundbreaking drug trial to osteosarcoma patients in record time.
Optimism surrounds osteosarcoma research as the OSI awards $1.1 million in cancer research funding to three innovative projects.
No results found.
Sign Up to Receive The Frontline
at vero eos et accusamus et iusto odio dignis simos duccimus qui blanditis
We never sell or share your information.
Your donation provides immediate and long-term support to osteosarcoma patients.